Chromatin nucleoprotein complexes containing tightly bound c-abl, p53 and bcl-2 gene sequences: Correlation with progression of chronic myelogenous leukemia

Gene

Volumn 169, Issue 2, 1996, Pages 173-178

  Nicolson, Nancy L ^a,b   Talpaz, Moshe ^a   Nicolson, Garth L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Rhodon Found for Biomed Research   (United States)

Author keywords

Gene complexes; Leukemia progression; Oncogene; Suppressor gene

Indexed keywords

NUCLEOPROTEIN;

ARTICLE; CHROMATIN; CHRONIC MYELOID LEUKEMIA; DNA BINDING; DNA SEQUENCE; HUMAN; ONCOGENE; PRIORITY JOURNAL; SUPPRESSOR GENE;

EID: 0029897894     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1119(96)88650-1     Document Type: Article

References (23)

1. Alimena, G., Morra, E., Lazzarino, M., Liberati, A.M., Montefusco, E., Inverardi, D., Bernasconi, P., Mancini, M., Donti, E., Grignani, F., Bernasconi, C., Dianzani, F. and Mandelli, F.: Interferon alpha-2b as therapy for Ph-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration. Blood 72 (1988) 642-647.
2. Fu, X.-Y. and Zhang, J.-J.: Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell 74 (1993) 1135-1145.
3. Hansen, R.M. and Borden, E.C.: Current status of interferons in the treatment of cancer. Oncology 6 (1992) 19-25.
4. Hubbell, H.R., Liu, R.-S. and Maxwell, B.L.: Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA. Cancer Res. 44 (1984) 3252-3257.
5. Kimura, H.: Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc. Natl. Acad. Sci. USA 90 (1993) 2165-2169.
6. Maniatis, T., Fritsch, E.F. and Sambrook, J.: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982.
7. Maxwell, B., Talpaz, M, and Gutterman, J.U.: Down-regulation of peripheral blood cell interferon receptors in chronic myelogenous leukemia patients undergoing human (HuIFN) therapy. Int. J. Cancer 36 (1985) 23-28.
8. 125I-labelled human α interferon to human lymphoid cells. Int. J. Cancer 28 (1981) 575-582.
9. Nicolson, G.L.: Ultrastructural analysis of toxin binding and entry into mammalian cells. Nature 251 (1974) 628-630.
10. Nicolson, G.L., Lacorbiere, M. and Hunter, T.R.: Mechanism of cell entry and toxicity of an affinity purified lectin from Ricinus communis and its differential effects on normal and virus-transformed fibroblasts. Cancer Res. 35 (1975) 144-155.
11. Nicolson, N.L., Talpaz, M. and Nicolson, G.L.: Interferon-α directly inhibits DNA polymerase activity in isolated chromatin nucleoprotein complexes: correlation with IFN-α treatment outcome in patients with chronic myelogenous leukemia. Gene 159 (1995) 105-111.
12. Ozer, H.: Biotherapy of CML with interferon. Semin. Oncol. 15 (1990) 14-20 (Suppl. 5).
13. Pepin, R.A., Lucus, R.B., Lang, R.B., Liau, M.-J. and Testa, D.: Detection of picogram amounts of nucleic acid by dot-blot hybridization. Biotechnology 8 (1990) 628-632.
14. Podlecki, D.A., Smith, R.M., Kao, M., Tsai, P., Huecksteadt, T., Brandenburg, D., Lasher, R.S., Jarett, L. and Olefsky, J.M.: Nuclear translocation of the insulin receptor. J. Biol. Chem. 262 (1987) 3362-3368.
15. Rosenberg-Nicolson, N.L. and Nicolson, G.L.: Nucleoprotein complexes released from metastatic cells that contain the abl oncogene and RNA and DNA polymerase and RNA primase activities. J. Cell. Biochem. 50 (1992a) 43-52.
16. Rosenberg-Nicolson, N.L. and Nicolson, G.L.: Nucleoproteins derived-from RNA polymerase complexes possess transcription activities and regulatory properties in vitro. J. Cell. Biochem. 50 (1992b) 301-312.
17. Rosenberg-Nicolson, N.L. and Nicolson, G.L.: Nucleoprotein complexes from metastatic cells containing oncogenes and tissue-specific genes: A novel method to track genes associated with specific nucleoproteins. Cancer Detect. Prev. 18 (1993) 31-42.
18. Rosenberg-Nicolson, N.L. and Nicolson, G.L.: The isolation, purification and analysis of specific gene-containing nucleoproteins and nucleoprotein complexes. Methods Mol. Genet. 5 (1994a) 281-298.
19. Rosenberg-Nicolson, N.L. and Nicolson, G.L.: The p53 gene is bound to specific nucleoproteins of nonmetastatic and metastatic murine large-cell lymphoma cells. Cancer Mol. Biol. 1 (1994b) 95-106.
20. Talpaz, M., Kantarjian, H., Kurzrock, R. and Gutterman, J.U.: Update on therapeutic options for chronic myelogenous leukemia with interferon. Semin. Hematol. 27 (1990) 31-36 (Suppl. 4).
21. Talpaz, M., Kantarjian, H., Kurzrock, R., Trujillo, J.M. and Gutterman, J.U.: Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann. Intern. Med. 114 (1991) 532-538.
22. Talpaz, M., Kantarjian, H., McCredie, K., Trujillo, J.M., Keating, M.J. and Gutterman, J.U.: Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in CML. N. Engl. J. Med. 314 (1986) 1065-1066.
23. NEU tyrosine kinase and its association with transcriptional transactivation. Biochem. Biophys. Res. Commun. 203 (1994) 1589-1598.